Flow cytometric DNA analysis combined with fine needle aspiration biopsy in the diagnosis of palpable metastases.
To determine the diagnostic value of flow cytometric (FCM) DNA analysis in combination with fine needle aspiration (FNA) biopsy, the nuclear DNA content was analyzed in FNA specimens from 155 superficial metastases and 60 benign lymph nodes. The results of FCM DNA analysis were considered to be positive for malignancy if DNA aneuploidy was found or if more than 12% S+G2M cells were present in the aspirate in diploid cases. The diagnostic accuracy of FCM DNA analysis alone in detecting malignancy was 92%, with a sensitivity of 91% and a specificity of 95%. FCM suggested the correct diagnosis in 5 of the 7 cytologically false-negative cases and in 9 of the 12 cytologically indeterminate or suspicious cases.
Joensuu
H
H
Department of Radiotherapy, University Central Hospital of Turku, Finland.
Klemi
P J
PJ
Eerola
E
E
D000782:Aneuploidy; D001707:Biopsy, Needle; D004247:DNA / Q000032:analysis*; D005434:Flow Cytometry; D006801:Humans; D007399:Interphase; D008198:Lymph Nodes / Q000473:pathology; D009362:Neoplasm Metastasis / Q000473:pathology*
D004247:DNA